Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr;44(4):1547-9.
doi: 10.1128/JCM.44.4.1547-1549.2006.

Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis

Juyan Zhou  1 , Elizabeth Garber, Manisha Desai, Lisa Saiman
Affiliations

Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis

Juyan Zhou et al. J Clin Microbiol. 2006 Apr.

Abstract

Respiratory tract specimens from patients with cystic fibrosis (CF) require unique processing by clinical microbiology laboratories to ensure detection of all potential pathogens. The present study sought to determine the compliance of microbiology laboratories in the United States with recently published recommendations for CF respiratory specimens. Microbiology laboratory protocols from 150 of 190 (79%) CF care sites were reviewed. Most described the use of selective media for Burkholderia cepacia complex (99%), Staphylococcus aureus (82%), and Haemophilus influenzae (89%) and identified the species of all gram-negative bacilli (87%). Only 52% delineated the use of agar diffusion assays for susceptibility testing of Pseudomonas aeruginosa. Standardizing laboratory practices will improve treatment, infection control, and our understanding of the changing epidemiology of CF microbiology.

PubMed Disclaimer

References

    1. Burns, J. L., L. Saiman, S. Whittier, J. Krzewinski, Z. Liu, D. Larone, S. A. Marshall, and R. N. Jones. 2001. Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 39:257-260. - PubMed
    1. Burns, J. L., L. Saiman, S. Whittier, D. Larone, J. Krzewinski, Z. Liu, S. A. Marshall, and R. N. Jones. 2000. Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J. Clin. Microbiol. 38:1818-1822. - PMC - PubMed
    1. Canadian Cystic Fibrosis Foundation. 1993. Microbiologic processing of respiratory specimens from patients with cystic fibrosis. Recommendations of the Clinical Subcommittee of the Medical/Scientific Advisory Committee of the Canadian CF Foundation. Can. J. Infect. Dis. 4:166-169. - PMC - PubMed
    1. Carson, L. A., O. C. Tablan, L. B. Cusick, W. R. Jarvis, M. S. Favero, and L. A. Bland. 1988. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J. Clin. Microbiol. 26:2096-2100. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. 15th informational supplement, vol. 25. Clinical and Laboratory Standards Institute, Wayne, PA.

Publication types

MeSH terms